FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049277834> ?p ?o ?g. }

• W2049277834 endingPage "141" @default.
• W2049277834 startingPage "133" @default.
• W2049277834 abstract "Fenvalerate (Fen), widely used for its high insecticidal potency and low mammalian toxicity, is classified as an endocrine-disrupting chemical. Recently, Fen has received great attention for its adverse effects on human reproductive health. In this study, we found that Fen (10 μM) had a stimulatory effect on the growth of both cell lines at 24 h compared with controls by MTS (p < 0.01) and BrdU (p < 0.01) assays in hormonally responsive uterine leiomyoma (UtLM) cells and normal uterine smooth muscle cells (UtSMC). Flow cytometry results showed that Fen enhanced the escape of cells from the G0–G1 checkpoint and promoted progression of both cell types into the S phase. An Annexin V assay showed that Fen had an anti-apoptotic effect on both cell types. By Real-time PCR, we found that collagen I mRNA expression increased (p < 0.05) in Fen-treated cells compared to controls, although it was greater in UtLM tumor cells. Accordingly, Fen increased (p < 0.05) collagen I protein levels in both cell lysate and supernatant when compared to controls. To further test the mechanism of Fen's effects, transactivation and competitive binding assays were done. The results showed Fen did not significantly stimulate luciferase activity at concentrations of 0.1 μM, 1.0 μM or 10.0 μM in either of the cell types. Competitive binding assays revealed that the affinity of Fen binding to estrogen receptors (ERs) was non-detectable compared to E2. Our data show that Fen can stimulate the growth of both UtLM cells and UtSMC, which involves a combination of enhanced cell cycle progression and inhibition of apoptosis. Also this compound can increase collagen I expression, at both mRNA and protein levels. Interestingly, the ER is less likely involved in either the hyperplasia or extracellular matrix (ECM) overproduction induced by Fen. Our results indicate that Fen exposure could be considered a novel risk factor for uterine fibroids through molecular mechanisms that do not directly involve the ERs." @default.
• W2049277834 created "2016-06-24" @default.
• W2049277834 creator A5009066152 @default.
• W2049277834 creator A5037426636 @default.
• W2049277834 creator A5070979789 @default.
• W2049277834 creator A5076513477 @default.
• W2049277834 creator A5076691464 @default.
• W2049277834 creator A5079303450 @default.
• W2049277834 creator A5079954893 @default.
• W2049277834 creator A5085886216 @default.
• W2049277834 date "2010-07-01" @default.
• W2049277834 modified "2023-09-30" @default.
• W2049277834 title "An endocrine-disrupting chemical, fenvalerate, induces cell cycle progression and collagen type I expression in human uterine leiomyoma and myometrial cells" @default.
• W2049277834 cites W123005099 @default.
• W2049277834 cites W14271546 @default.
• W2049277834 cites W171201224 @default.
• W2049277834 cites W1895533409 @default.
• W2049277834 cites W1928410426 @default.
• W2049277834 cites W1965192117 @default.
• W2049277834 cites W1969579546 @default.
• W2049277834 cites W1975286375 @default.
• W2049277834 cites W1977014139 @default.
• W2049277834 cites W1979635646 @default.
• W2049277834 cites W1984952650 @default.
• W2049277834 cites W1986862073 @default.
• W2049277834 cites W1991688869 @default.
• W2049277834 cites W1997350963 @default.
• W2049277834 cites W2006112787 @default.
• W2049277834 cites W2008247501 @default.
• W2049277834 cites W2010747883 @default.
• W2049277834 cites W2015348909 @default.
• W2049277834 cites W2027536141 @default.
• W2049277834 cites W2038743660 @default.
• W2049277834 cites W2041617605 @default.
• W2049277834 cites W2042124938 @default.
• W2049277834 cites W2046401222 @default.
• W2049277834 cites W2047374996 @default.
• W2049277834 cites W2056771617 @default.
• W2049277834 cites W2065633639 @default.
• W2049277834 cites W2069081394 @default.
• W2049277834 cites W2071262171 @default.
• W2049277834 cites W2093612217 @default.
• W2049277834 cites W2108656984 @default.
• W2049277834 cites W2120775052 @default.
• W2049277834 cites W2123859624 @default.
• W2049277834 cites W2132180344 @default.
• W2049277834 cites W2137433034 @default.
• W2049277834 cites W2144708908 @default.
• W2049277834 cites W2149110836 @default.
• W2049277834 cites W2156217595 @default.
• W2049277834 cites W2162603825 @default.
• W2049277834 cites W2164991984 @default.
• W2049277834 cites W2170763972 @default.
• W2049277834 cites W2411369227 @default.
• W2049277834 cites W2411758898 @default.
• W2049277834 cites W4231905013 @default.
• W2049277834 cites W4239973879 @default.
• W2049277834 cites W4245903632 @default.
• W2049277834 cites W4255664903 @default.
• W2049277834 cites W4301100767 @default.
• W2049277834 cites W2029883951 @default.
• W2049277834 doi "https://doi.org/10.1016/j.toxlet.2010.03.004" @default.
• W2049277834 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2937012" @default.
• W2049277834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20230880" @default.
• W2049277834 hasPublicationYear "2010" @default.
• W2049277834 type Work @default.
• W2049277834 sameAs 2049277834 @default.
• W2049277834 citedByCount "29" @default.
• W2049277834 countsByYear W20492778342012 @default.
• W2049277834 countsByYear W20492778342014 @default.
• W2049277834 countsByYear W20492778342015 @default.
• W2049277834 countsByYear W20492778342016 @default.
• W2049277834 countsByYear W20492778342017 @default.
• W2049277834 countsByYear W20492778342018 @default.
• W2049277834 countsByYear W20492778342019 @default.
• W2049277834 countsByYear W20492778342020 @default.
• W2049277834 countsByYear W20492778342021 @default.
• W2049277834 countsByYear W20492778342023 @default.
• W2049277834 crossrefType "journal-article" @default.
• W2049277834 hasAuthorship W2049277834A5009066152 @default.
• W2049277834 hasAuthorship W2049277834A5037426636 @default.
• W2049277834 hasAuthorship W2049277834A5070979789 @default.
• W2049277834 hasAuthorship W2049277834A5076513477 @default.
• W2049277834 hasAuthorship W2049277834A5076691464 @default.
• W2049277834 hasAuthorship W2049277834A5079303450 @default.
• W2049277834 hasAuthorship W2049277834A5079954893 @default.
• W2049277834 hasAuthorship W2049277834A5085886216 @default.
• W2049277834 hasBestOaLocation W20492778342 @default.
• W2049277834 hasConcept C104317684 @default.
• W2049277834 hasConcept C121608353 @default.
• W2049277834 hasConcept C126322002 @default.
• W2049277834 hasConcept C1292079 @default.
• W2049277834 hasConcept C134018914 @default.
• W2049277834 hasConcept C1491633281 @default.
• W2049277834 hasConcept C150194340 @default.
• W2049277834 hasConcept C153911025 @default.
• W2049277834 hasConcept C170493617 @default.
• W2049277834 hasConcept C185592680 @default.

• next